These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 32438526)

  • 1. Effects of Neurod1 Expression on Mouse and Human Schwannoma Cells.
    Kersigo J; Gu L; Xu L; Pan N; Vijayakuma S; Jones T; Shibata SB; Fritzsch B; Hansen MR
    Laryngoscope; 2021 Jan; 131(1):E259-E270. PubMed ID: 32438526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Merlin status regulates p75(NTR) expression and apoptotic signaling in Schwann cells following nerve injury.
    Ahmad I; Fernando A; Gurgel R; Jason Clark J; Xu L; Hansen MR
    Neurobiol Dis; 2015 Oct; 82():114-122. PubMed ID: 26057084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth inhibitory and anti-tumour activities of OSU-03012, a novel PDK-1 inhibitor, on vestibular schwannoma and malignant schwannoma cells.
    Lee TX; Packer MD; Huang J; Akhmametyeva EM; Kulp SK; Chen CS; Giovannini M; Jacob A; Welling DB; Chang LS
    Eur J Cancer; 2009 Jun; 45(9):1709-20. PubMed ID: 19359162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemistry study of human vestibular nerve schwannoma differentiation.
    Hung G; Colton J; Fisher L; Oppenheimer M; Faudoa R; Slattery W; Linthicum F
    Glia; 2002 Jun; 38(4):363-70. PubMed ID: 12007148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interplay between VEGF-A and cMET signaling in human vestibular schwannomas and schwann cells.
    Dilwali S; Roberts D; Stankovic KM
    Cancer Biol Ther; 2015; 16(1):170-5. PubMed ID: 25692621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene-expression profiling elucidates molecular signaling networks that can be therapeutically targeted in vestibular schwannoma.
    Agnihotri S; Gugel I; Remke M; Bornemann A; Pantazis G; Mack SC; Shih D; Singh SK; Sabha N; Taylor MD; Tatagiba M; Zadeh G; Krischek B
    J Neurosurg; 2014 Dec; 121(6):1434-45. PubMed ID: 25245477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic effects of combined BET and FAK inhibition against Vestibular Schwannomas in NF2-related Schwannomatosis.
    González-Rodriguez MA; Troutman S; Bayle S; Lester DK; Grove M; Duckett D; Kareta MS; Kissil JL
    Oncogene; 2024 Sep; 43(40):2995-3002. PubMed ID: 39209965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Constitutive neuregulin-1/ErbB signaling contributes to human vestibular schwannoma proliferation.
    Hansen MR; Roehm PC; Chatterjee P; Green SH
    Glia; 2006 Apr; 53(6):593-600. PubMed ID: 16432850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorescent Detection of Merlin-deficient Schwann Cells and Primary Human Vestibular Schwannoma Cells Using Sodium Fluorescein.
    Perez ER; Bracho O; Ein L; Szczupak M; Monje PV; Fernandez-Valle C; Alshaiji A; Ivan M; Morcos J; Liu XZ; Hoffer M; Eshraghi A; Angeli S; Telischi F; Dinh CT
    Otol Neurotol; 2018 Sep; 39(8):1053-1059. PubMed ID: 30001282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neurotrophic factor expression in vestibular schwannoma. An overview].
    Diensthuber M; Lenarz T; Stöver T
    Laryngorhinootologie; 2006 Oct; 85(10):731-7. PubMed ID: 16612755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NeuroD1 Dictates Tumor Cell Differentiation in Medulloblastoma.
    Cheng Y; Liao S; Xu G; Hu J; Guo D; Du F; Contreras A; Cai KQ; Peri S; Wang Y; Corney DC; Noronha AM; Chau LQ; Zhou G; Wiest DL; Bellacosa A; Wechsler-Reya RJ; Zhao Y; Yang ZJ
    Cell Rep; 2020 Jun; 31(12):107782. PubMed ID: 32579914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of sporadic and neurofibromatosis type 2-associated vestibular schwannoma growth in vitro and in vivo after treatment with the c-Jun N-terminal kinase inhibitor AS602801.
    Dougherty MC; Shibata SB; Clark JJ; Canady FJ; Yates CW; Hansen MR
    J Neurosurg; 2023 Apr; 138(4):962-971. PubMed ID: 36087315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AR42, a novel histone deacetylase inhibitor, as a potential therapy for vestibular schwannomas and meningiomas.
    Bush ML; Oblinger J; Brendel V; Santarelli G; Huang J; Akhmametyeva EM; Burns SS; Wheeler J; Davis J; Yates CW; Chaudhury AR; Kulp S; Chen CS; Chang LS; Welling DB; Jacob A
    Neuro Oncol; 2011 Sep; 13(9):983-99. PubMed ID: 21778190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical profile of cytokines and growth factors expressed in vestibular schwannoma and in normal vestibular nerve tissue.
    Taurone S; Bianchi E; Attanasio G; Di Gioia C; Ierinó R; Carubbi C; Galli D; Pastore FS; Giangaspero F; Filipo R; Zanza C; Artico M
    Mol Med Rep; 2015 Jul; 12(1):737-45. PubMed ID: 25738867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical assessment of MEK1/2 inhibitors for neurofibromatosis type 2-associated schwannomas reveals differences in efficacy and drug resistance development.
    Fuse MA; Dinh CT; Vitte J; Kirkpatrick J; Mindos T; Plati SK; Young JI; Huang J; Carlstedt A; Franco MC; Brnjos K; Nagamoto J; Petrilli AM; Copik AJ; Soulakova JN; Bracho O; Yan D; Mittal R; Shen R; Telischi FF; Morrison H; Giovannini M; Liu XZ; Chang LS; Fernandez-Valle C
    Neuro Oncol; 2019 Mar; 21(4):486-497. PubMed ID: 30615146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-Cell RNA-Seq Reveals Heterogeneity of Cell Communications between Schwann Cells and Fibroblasts within Vestibular Schwannoma Microenvironment.
    Xu M; Wang S; Jiang Y; Wang J; Xiong Y; Dong W; Yao Q; Xing Y; Liu F; Chen Z; Yu D
    Am J Pathol; 2022 Sep; 192(9):1230-1249. PubMed ID: 35750260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of MEK pathway in vestibular schwannoma cell culture.
    Neff BA; Voss SG; Schmitt WR; Driscoll CL; Link MJ; Beatty CW; Kita H
    Laryngoscope; 2012 Oct; 122(10):2269-78. PubMed ID: 22886786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination therapy with mTOR kinase inhibitor and dasatinib as a novel therapeutic strategy for vestibular schwannoma.
    Sagers JE; Beauchamp RL; Zhang Y; Vasilijic S; Wu L; DeSouza P; Seist R; Zhou W; Xu L; Ramesh V; Stankovic KM
    Sci Rep; 2020 Mar; 10(1):4211. PubMed ID: 32144278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptomic Profile Reveals Deregulation of Hearing-Loss Related Genes in Vestibular Schwannoma Cells Following Electromagnetic Field Exposure.
    Colciago A; Audano M; Bonalume V; Melfi V; Mohamed T; Reid AJ; Faroni A; Greer PA; Mitro N; Magnaghi V
    Cells; 2021 Jul; 10(7):. PubMed ID: 34360009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The importance of nerve microenvironment for schwannoma development.
    Schulz A; Büttner R; Hagel C; Baader SL; Kluwe L; Salamon J; Mautner VF; Mindos T; Parkinson DB; Gehlhausen JR; Clapp DW; Morrison H
    Acta Neuropathol; 2016 Aug; 132(2):289-307. PubMed ID: 27236462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.